Search

Search results

375 results found

Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials.

Kimball, Alexandra B, Murali Sundaram, Alan L Shields, Stacie Hudgens, Martin Okun, Catherine Foley, and Arijit Ganguli. 2018. “Adalimumab Alleviates Skin Pain in Patients With Moderate-to-Severe Hidradenitis Suppurativa: Secondary Efficacy Results from the PIONEER I and PIONEER II Randomized Controlled Trials.”. Journal of the American Academy of Dermatology 79 (6): 1141-43.

PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

Papp, Kim A, Bruce Strober, Matthias Augustin, Steve Calabro, Anil Londhe, Marc Chevrier, and PSOLAR investigators and Steering Committee. 2012. “PSOLAR: Design, Utility, and Preliminary Results of a Prospective, International, Disease-Based Registry of Patients With Psoriasis Who Are Receiving, or Are Candidates For, Conventional Systemic Treatments or Biologic Agents.”. Journal of Drugs in Dermatology : JDD 11 (10): 1210-7.

Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.

Alora-Palli, Maria B, Alexis C Perkins, Alicia Van Cott, and Alexandra B Kimball. 2010. “Efficacy and Tolerability of a Cosmetically Acceptable Coal Tar Solution in the Treatment of Moderate Plaque Psoriasis: A Controlled Comparison With Calcipotriene (calcipotriol) Cream.”. American Journal of Clinical Dermatology 11 (4): 275-83.